[Retracted] Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma

Table 2

Univariate analysis of clinicopathological characteristics of patients with hepatoma in the MVI-positive group and MVI-negative group.

Hepatoma,
	MVI
	Negative (%)	Positive (%)		value
Age (years)			0.204	0.652
<60	8 (23.53%)	8 (28.57%)
≥60	26 (76.47%)	20 (71.43%)
HBsAg			0.150	0.698
Positive	24 (70.59%)	21 (75.00%)
Negative	10 (29.41%)	7 (25.00%)
Tumor size (cm)			10.620	0.001
≤3	25 (73.53%)	9 (32.14%)
>3	9 (26.47%)	19 (67.86%)
AFP (μg/mL)			10.524	0.001
<200	29 (85.29%)	12 (42.86%)
≥200	5 (14.71%)	16 (57.14%)
Edmondson grade			20.736	<0.001
I–II	27 (79.41%)	6 (21.43%)
III–IV	7 (20.59%)	22 (78.57%)
ALT (U/L)			0.005	0.942
<40	24 (68.28%)	20 (71.43%)
≥40	10 (31.72%)	8 (28.57%)
AST (U/L)			0.105	0.746
<40	22 (64.71%)	17 (60.71%)
≥40	12 (35.29%)	11 (39.29%)
NLR			8.744	0.003
<1.520	18 (52.94%)	4 (14.29%)
≥1.520	16 (47.06%)	24 (85.71%)
PLR			2.702	0.100
<98	18 (52.94%)	9 (32.14%)
≥98	16 (47.06%)	19 (67.86%)
APRI			4.849	0.028
<0.275	24 (70.59%)	12 (42.86%)
≥0.275	10 (29.41%)	16 (57.14%)
CEA (μg/L)			0.285	0.594
<5	29 (85.29%)	26 (92.86%)
≥5	5 (14.71%)	2 (7.14%)
CA19-9 (U/mL)			0.007	0.932
<37	29 (85.29%)	25 (89.29%)
≥37	5 (14.71%)	3 (10.71%)
Number of tumors			6.115	0.113
Single	29 (85.29%)	16 (57.14%)
Multiple	5 (14.71%)	12 (42.86%)